Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Frailty and Mortality in Dialysis: Evaluation of a Clinical Frailty Scale.

Alfaadhel TA, Soroka SD, Kiberd BA, Landry D, Moorhouse P, Tennankore KK.

Clin J Am Soc Nephrol. 2015 Mar 4. pii: CJN.07760814. [Epub ahead of print]

PMID:
25739851
2.

Geographic and facility-level variation in the use of peritoneal dialysis in Canada: a cohort study.

Sood MM, Tangri N, Hiebert B, Kappel J, Dart A, Levin A, Manns B, Molzahn A, Naimark D, Nessim SJ, Rigatto C, Soroka SD, Zappitelli M, Komenda P; Canadian Kidney Knowledge Translation; Generation Network.

CMAJ Open. 2014 Mar 27;2(1):E36-44. doi: 10.9778/cmajo.20130050. eCollection 2014 Jan.

3.

Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.

Stoddard RA, Quinn CP, Schiffer JM, Boyer AE, Goldstein J, Bagarozzi DA, Soroka SD, Dauphin LA, Hoffmaster AR.

J Immunol Methods. 2014 Jun;408:78-88. doi: 10.1016/j.jim.2014.05.008. Epub 2014 May 22.

PMID:
24857756
4.

An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis.

Wilson JA, Goralski KB, Soroka SD, Morrison M, Mossop P, Sleno L, Wang Y, Anderson DR.

J Clin Pharmacol. 2014 Aug;54(8):901-9. doi: 10.1002/jcph.335. Epub 2014 May 28.

PMID:
24846496
5.

Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.

Moist LM, Troyanov S, White CT, Wazny LD, Wilson JA, McFarlane P, Harwood L, Sood MM, Soroka SD, Bass A, Manns BJ.

Am J Kidney Dis. 2013 Nov;62(5):860-73. doi: 10.1053/j.ajkd.2013.08.001. Epub 2013 Sep 17.

PMID:
24054466
6.

Oral sodium thiosulfate as maintenance therapy for calcific uremic arteriolopathy: a case series.

AlBugami MM, Wilson JA, Clarke JR, Soroka SD.

Am J Nephrol. 2013;37(2):104-9. doi: 10.1159/000346410. Epub 2013 Jan 25.

PMID:
23363879
7.
8.

Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective.

Vegter S, Tolley K, Keith MS, Lok CE, Soroka SD, Morton AR.

Clin Ther. 2012 Jul;34(7):1531-43. doi: 10.1016/j.clinthera.2012.06.006. Epub 2012 Jun 27.

PMID:
22742885
9.

KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron.

Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, Ossowski S, Caulfield M; International Consortium for Blood Pressure (ICBP), Bruneval P, Estivill X, Froguel P, Hadchouel J, Schott JJ, Jeunemaitre X.

Nat Genet. 2012 Mar 11;44(4):456-60, S1-3. doi: 10.1038/ng.2218. Erratum in: Nat Genet. 2012;44(5):609.

PMID:
22406640
10.

Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study.

Tennankore KK, Soroka SD, West KA, Kiberd BA.

BMC Nephrol. 2011 May 11;12:19. doi: 10.1186/1471-2369-12-19.

11.

Mineral metabolism management in Canadian peritoneal dialysis patients.

Soroka SD, Beard KM, Mendelssohn DC, Cournoyer SH, Da Roza GA, Geary DF.

Clin Nephrol. 2011 May;75(5):410-5.

PMID:
21543020
12.

Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial.

Wilkieson TJ, Ingram AJ, Crowther MA, Soroka SD, Nagai R, Jindal KK, Clase CM.

Clin J Am Soc Nephrol. 2011 May;6(5):1018-24. doi: 10.2215/CJN.07240810. Epub 2011 Apr 14.

13.

Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.

Veguilla V, Hancock K, Schiffer J, Gargiullo P, Lu X, Aranio D, Branch A, Dong L, Holiday C, Liu F, Steward-Clark E, Sun H, Tsang B, Wang D, Whaley M, Bai Y, Cronin L, Browning P, Dababneh H, Noland H, Thomas L, Foster L, Quinn CP, Soroka SD, Katz JM.

J Clin Microbiol. 2011 Jun;49(6):2210-5. doi: 10.1128/JCM.00229-11. Epub 2011 Apr 6.

14.

A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials.

Soroka SD, Schiffer JM, Semenova VA, Li H, Foster L, Quinn CP.

Biologicals. 2010 Nov;38(6):675-83. doi: 10.1016/j.biologicals.2010.09.001. Epub 2010 Sep 28.

PMID:
20875951
15.

Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.

Lebner AC, Beard KM, Soroka SD, Cournoyer SH, Da Roza GA, Geary DF, Mendelssohn DC.

Nephrol Dial Transplant. 2011 Jan;26(1):156-63. doi: 10.1093/ndt/gfq459. Epub 2010 Jul 28.

16.

Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

Manns BJ, Hodsman A, Zimmerman DL, Mendelssohn DC, Soroka SD, Chan C, Jindal K, Klarenbach S.

Am J Kidney Dis. 2010 May;55(5):800-12. doi: 10.1053/j.ajkd.2010.02.339. No abstract available.

PMID:
20438984
17.

Nephrology consults increase.

Kiberd BA, Soroka SD.

Kidney Int. 2010 Apr;77(7):645. doi: 10.1038/ki.2009.526. No abstract available.

PMID:
20224586
18.

Topic maps for exploring nosological, lexical, semantic and HL7 structures for clinical data.

Paterson GI, Grant AM, Soroka SD.

Health Informatics J. 2008 Dec;14(4):267-78. doi: 10.1177/1460458208096556.

PMID:
19008277
19.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP; Anthrax Vaccine Research Program Working Group.

JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532. Erratum in: JAMA. 2008 Nov 19;300(19):2252.

PMID:
18827210
20.

A prospective evaluation of renal replacement therapy modality eligibility.

Mendelssohn DC, Mujais SK, Soroka SD, Brouillette J, Takano T, Barre PE, Mittal BV, Singh A, Firanek C, Story K, Finkelstein FO.

Nephrol Dial Transplant. 2009 Feb;24(2):555-61. doi: 10.1093/ndt/gfn484. Epub 2008 Aug 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk